Fig. 1From: The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID studyOCT image showing presence of SRF (<200 μm height) within the subfoveal region of the macula that constitutes disease activity in the Intensive retinal fluid arm onlyBack to article page